‘Regulatory whiplash’ as FDA decides to review Moderna flu shot
FDA Reversal Paves the Way for Moderna’s mRNA Flu Vaccine The US Food and Drug Administration (FDA) has reversed its initial decision and will now review Moderna’s application for its innovative messenger RNA (mRNA)-based flu vaccine. This dramatic shift comes after a contentious back-and-forth with the pharmaceutical company, initially sparked by concerns over the clinical … Read more